This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Epigenetic Therapies And Technologies: World Market Prospects 2013-2023

Ordering now lets you discover commercial prospects to 2023 for epigenetics

Visiongain's study is for everyone needing forward-looking analysis of pharmaceutical and diagnostic biotechnology. You find data, trends and predictions. Please ask for our report now.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

Table of Contents 1. Executive Summary

1.1 Epigenetic Therapies and Technologies: World Market Review1.2 Report Contents1.3 Research and Analysis Methods

2. An Introduction to Epigenetics

2.1 How is Epigenetics Defined?

2.1.1 Epigenetic Mechanisms

2.1.2 A Brief History of Epigenetic Research

2.2 The Links between Epigenetics and Disease

2.2.1 The Role of Lifestyle in Epigenetics

2.2.2 Epigenetics and Cancer

2.2.3 Epigenetics in Inherited Disorders

2.2.4 Epigenetics in Neurological Diseases

2.3 Epigenetics for Disease Diagnosis

2.3.1 Diagnosing for Breast Cancer

2.3.2 Colorectal Cancer: The Importance of Early Diagnosis

2.3.3 Diagnostics for Lung Cancer: Difficulty in Accessing Samples

2.3.4 Diagnostics for Prostate Cancer

2.4 The Use of Epigenetics in Treating Disease

2.4.1 DNA Methyltransferase (DNMT) Inhibitors

2.4.1.1 Myelodysplastic Syndromes (MDS)

2.4.2 Histone Deacetylase (HDAC) Inhibitors

2.4.2.1 Cutaneous T Cell Lymphoma (CTCL)

2.4.2.2 Peripheral T Cell Lymphoma (PTCL)

2.5 Drug Discovery and Development Tools Using Epigenetics

2.5.1 Bisulphite Screening for DNA Methylation

2.5.2 Chromatin Immunoprecipitation (ChIP) for Histone Modification

3. The Epigenetic Therapies and Technologies Market 2013-2023

3.1 The Epigenetic Therapies and Technologies Market 2011-20123.1.1 Leading Sectors of the Market 2011-20123.2 The Epigenetic Therapies and Technologies Market 2013-20233.2.1 The Epigenetic Therapies and Technologies Market: Overall Revenue Forecast 2013-20233.2.2 What Will Drive Revenue Growth for Epigenetic Therapies and Technologies?3.2.3 Rising Importance for Diagnostics Revenue 2013-20233.3 Epigenetic Therapies Submarket 2013-20233.3.1 Epigenetic Therapies Submarket: Revenue Forecast 2013-20233.3.2 Factors Influencing Epigenetic Therapy Uptake and Revenues 2013-20233.4 Epigenetic Technologies Submarket 2013-20233.4.1 Epigenetic Technologies Submarket: Revenue Forecast 2013-20233.4.2 Epigenetic Technologies Submarket: Drivers and Restraints 2013-20233.5 Epigenetic Diagnostics Submarket 2013-20233.5.1 Epigenetic Diagnostics Submarket: Revenue Forecast 2013-20233.5.2 New Product Launches to Drive Growth 2013-2023

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,403.14 +140.58 0.86%
S&P 500 1,859.14 +16.16 0.88%
NASDAQ 4,076.4510 +42.29 1.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs